Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Rachel Hamburger is a businesswoman with over 20 years of experience in senior managerial positions and an investor in various Biomed companies. She has a broad background in financial and operational disciplines. She is also the Chairperson at Pepticom Ltd., an AI company for the discovery of novel molecules in the Pharmaceutical and Agricultural markets, since 2014.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Rachel Hamburger's primary investment focus?
- Rachel Hamburger has invested in the Health Tech & Life Sciences sector, with one recorded investment in Pepticom.
- When was Rachel Hamburger's most recent investment activity?
- Rachel Hamburger's most recent recorded investment activity was in August 2013.
- Can you name a notable company in Rachel Hamburger's portfolio?
- A notable company in Rachel Hamburger's portfolio is Pepticom, which develops novel peptide drug candidates.
- What stage of funding does Rachel Hamburger typically participate in?
- Rachel Hamburger has participated in Seed stage funding rounds, as seen with the investment in Pepticom.
- What is the funding stage and amount raised by Pepticom, a company in Rachel Hamburger's portfolio?
- Pepticom, a company in Rachel Hamburger's portfolio, is at Series A stage and has raised $14.2M.